BDNF and major depressive disorder: In addition to the well-established correlation between antidepressant therapy and increase of BDNF expression in hippocampus and PFC of depressed patients [202], monoamine deficiency is regarded as the main explicative hypothesis of depression pathophysiology and, consequently, SSRIs, SNRIs and MAO inhibitors the major remedial therapeutics.